Alison Haile

Alison has spent most of her career since qualification working directly with in-house general counsel, solicitors, CEOs and inventors of pharmaceutical companies and their licensees. She is experienced in managing and prosecuting large patent portfolios worldwide (100+ families) and providing full strategic advice and opinions in relation to all patent-related aspects of her client’s business and their interactions with third parties. She also enjoys working with in-house patent attorneys and providing European and UK patent expertise to attorneys in other jurisdictions. 

The core of Alison’s practice lies in chemistry and life sciences with a focus on the pharmaceutical and nutritional sectors, particularly in relation to drug formulations, new medical uses, drug combinations, dosage regimes, drug delivery, pharmaceutical chemistry, nutritional supplements, foodstuffs, cosmetic formulations and pharmaceutical patent life-cycle management. 

In addition to drafting, global prosecution, portfolio management and representing her clients before the European Patent Office (EPO) and the UK Intellectual Property Office (UKIPO), Alison is experienced in due diligence for high value mergers & acquisitions and licensing agreements. A significant portion of her practice also involves coordinating the filing and prosecution of SPCs and paediatric extensions Europe-wide and she has given presentations in the US on SPC law. 

Alison joined Mathys & Squire in 2019 and was previously a Partner in the London office of an Am Law 100 firm and a Partner at another London firm.